InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
81.95
(
-0.21%
)
Bitcoin
66,398.46
(
-0.36%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

nivasvs

Send PM Follow Ignore
Followers 3
Posts 147
Boards Moderated 0
Alias Born 07/16/2006

nivasvs

Re: anotherbiotechguy post# 4017

Tuesday, 07/03/2007 12:31:56 PM

Tuesday, July 03, 2007 12:31:56 PM

Post# of 19309
There will be a separate session on Atryn by Leo/GTCB.

See Page 7 of the link.


http://www.isth2007.com/final/Lunch_Sessions.pdf

GTC Biotherapeutics / LEO Pharma

ATryn®, the first recombinant antithrombin; innovation or alternative?
Chairperson: M. von Depka

Introduction & Welcome
M. von Depka 13:00 - 13:05

The transgenic production system; an emphasis on safety & purity
H. Meade 13:05 - 13:20

ATryn®, an alternative to plasma derived antithrombin
M. von Depka 13:20 - 13:35

Discussion
Chairpersons and Faculty 13:35 - 13:45
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up